RCT EVIDENCE ON TIME-IN-RANGE IN TYPE 1 DIABETES

被引：0
|
作者：
Battelino, T. [1 ]
Danne, T. [2 ]
Edelman, S. [3 ]
Choudhary, P. [4 ]
Renard, E. [5 ]
Westerbacka, J. [6 ]
Mukherjee, B. [6 ]
Picard, P. [7 ]
Pilorget, V. [8 ]
Bergenstal, R. [9 ]
机构：
[1] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[2] Childrens & Youth Hosp Bult, Diabet Ctr Children & Adolescents, Hannover, Germany
[3] Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, San Diego, CA 92161 USA
[4] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[5] Montpellier Univ Hosp, Dept Endocrinol Diabet & Nutr, Montpellier, France
[6] Sanofi, Global Med Affairs, Paris, France
[7] IVIDATA Life Sci, Biostat, Levallois Perret, France
[8] Sanofi, R&d, Paris, France
[9] Healthpartners Inst, Int Diabet Ctr, Minneapolis, MN USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IS029 / #9
引用
收藏
页码：A11 / A12
页数：2
相关论文
共 50 条
  • [31] Newly Diagnosed Pediatric Patients with Type 1 Diabetes Show Steady Decline in Glucose Time-in-Range (TIR) over 1 Year: Pilot Study
    Zaharieva, Dessi
    Prahalad, Priya
    Addala, Ananta
    Scheinker, David
    Desai, Manisha
    Hood, Korey K.
    Leverenz, Brianna
    Maahs, David M.
    DIABETES, 2020, 69
  • [32] Variation of glucose time in range in type 1 diabetes
    Hansen, Klavs Wurgler
    Bibby, Bo Martin
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (06)
  • [33] A moderately higher time-in-range threshold improves the prognosis of type 2 diabetes patients complicated with COVID-19
    Cong, Riping
    Zhang, Jianbo
    Xu, Lujia
    Zhang, Yujian
    Wang, Hao
    Wang, Jing
    Wang, Wei
    Diao, Yingli
    Liu, Haijiao
    Zhang, Jing
    Tang, Kuanxiao
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [34] Does HbA1c Accurately Predict Time-in-Range?
    Dixon, Ronald F.
    Miller, David P.
    Majithia, Amit
    Lee, Amy Armento
    Robertson, Scott
    Germanos, Mary Jo
    Zisser, Howard
    DIABETES, 2019, 68
  • [35] Time-in-range for monitoring glucose control: Is it time for a change?
    Bellido, Virginia
    Pines-Corrales, Pedro Jose
    Villar-Taibo, Rocio
    Ampudia-Blasco, Francisco Javier
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [36] Improvement in Time-in-Range (TIR) with Real-Life Use of Hybrid Closed-Loop System in Patients with Type 1 Diabetes (T1D)
    Akturk, Halis K.
    Giordano, Dominique A.
    Joseph, Hal
    Garg, Satish K.
    Snell-Bergeon, Janet K.
    DIABETES, 2019, 68
  • [37] RELATIONSHIP BETWEEN HEMOGLOBIN A1C, TIME-IN-RANGE AND GLYCEMIC VARIABILITY IN TYPE 1 DIABETES PATIENTS UNDER INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING.
    Diaz Soto, G.
    Gomez Hoyos, E.
    Jimenez, R.
    Nieto De La Marca, M. D. L. O.
    Vidueira, A. M.
    De Luis, D.
    Bahillo Curieses, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A124 - A124
  • [38] The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes
    Sekiguchi, Sho
    Yamada, Eijiro
    Nakajima, Yasuyo
    Matsumoto, Shunichi
    Yoshino, Satoshi
    Horiguchi, Kazuhiko
    Ishida, Emi
    Uehara, Ryota
    Okada, Shuichi
    Yamada, Masanobu
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (03): : 221 - 227
  • [39] GREATER DERIVED TIME-IN-RANGE IN PEOPLE WITH TYPE 2 DIABETES ADVANCING TO IGLARLIXI: A POOLED ANALYSIS OF THE LIXILAN CLINICAL TRIAL PROGRAMME
    Haluzik, M.
    Cheng, A.
    Frias, J. P.
    Al-Sofiani, M.
    Lauand, F.
    Souhami, E.
    Melas-Melt, L.
    Rosenstock, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A195 - A196
  • [40] TIME IN RANGE IN CHILDREN WITH TYPE 1 DIABETES IN A PEDIATRIC UNIT
    Silva, L.
    Belinha, F.
    Serra Caetano, J.
    Cardoso, R.
    Dinis, I.
    Mirante, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A175 - A175
12345